Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221). (Q43064864)
Jump to navigation
Jump to search
scientific article published in June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221). |
scientific article published in June 2010 |
Statements
1 reference
Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221). (English)
1 reference
Murielle M Véniant
1 reference
Clarence Hale
1 reference
Randall W Hungate
1 reference
Kyung Gahm
1 reference
Maurice G Emery
1 reference
Janan Jona
1 reference
Smriti Joseph
1 reference
Jeffrey Adams
1 reference
Andrew Hague
1 reference
George Moniz
1 reference
Jiandong Zhang
1 reference
Michael D Bartberger
1 reference
Vivian Li
1 reference
Rashid Syed
1 reference
Steven Jordan
1 reference
Renée Komorowski
1 reference
Michelle M Chen
1 reference
Rod Cupples
1 reference
Ki Won Kim
1 reference
David J St Jean
1 reference
Lars Johansson
1 reference
Martin A Henriksson
1 reference
Meredith Williams
1 reference
Jerk Vallgårda
1 reference
Christopher Fotsch
1 reference
Minghan Wang
1 reference
1 June 2010
1 reference
1 reference
53
1 reference
11
1 reference
4481-4487
1 reference
Identifiers
1 reference
1 reference